WorkLemon IVS: Financial statements 2019
CVR: 36560991
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
WorkLemon IVS (CVR 36560991) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -1,200 and a net result of DKK -12,390 compared with DKK -12,240 the year before. Equity in the 2019 report amounted to DKK 68,044. The solvency ratio was 99.8%.
- Gross Profit
- DKK -1,200
- Profit/Loss
- DKK -12,390
- Equity
- DKK 68,044
- Total Assets
- DKK 68,193
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -1 t. | -12 t. | 68 t. | - |
| 2018 | - | -1 t. | -12 t. | 79 t. | - |
| 2017 | - | -21 t. | -32 t. | 91 t. | - |
| 2016 | - | -6 t. | -13 t. | 68 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of November 29, 2019, Michael Søndahl Gad has stepped down as director of WorkLemon IVS.
As of July 30, 2019, Alexander Leo Nicolaj Ennis Tjernström has stepped down as adm. dir. of WorkLemon IVS.
WorkLemon IVS has published its annual report for 2018. Gross profit came to DKK -1,050, and the net result was DKK -12,240.
About WorkLemon IVS
WorkLemon IVS was a Danish company of the type Iværksætterselskab based in København N, founded in 2015. The company has been dissolved on 9 April 2021. The company was registered under the industry Anden udgivelse af software. In 2019, the company reported a gross profit of DKK -1,200 and a net result of DKK -12,390 compared with DKK -12,240 the year before. Equity in the 2019 report amounted to DKK 68,044.